Question 1

Does Wells Fargo own MNPR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Wells Fargo holds 3,958 shares of MNPR (Monopar Therapeutics), worth $366,471.

Question 2

How many shares of MNPR does Wells Fargo own?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo holds 3,958 shares of MNPR (Monopar Therapeutics).

Question 3

What is Wells Fargo's MNPR position worth?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo's MNPR position is worth $366,471.

Question 4

Is Wells Fargo buying or selling MNPR?

Accepted Answer

In Q2 2026, Wells Fargo increased its MNPR position by 2,230 shares (+129.1%).

Question 5

When did Wells Fargo first buy MNPR?

Accepted Answer

Wells Fargo first reported MNPR in its Q3 2024 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	3,958	+129.1%	$366,471	0.0%	$92.59	38
2026-Q1	Decreased	1,728	-66.3%	$94,678	0.0%	$54.79	0
2025-Q4	Increased	5,125	+120.8%	$334,664	0.0%	$65.30	38
2025-Q3	Increased	2,321	+0.9%	$189,556	0.0%	$81.67	16
2025-Q2	Increased	2,301	+820.4%	$82,330	0.0%	$35.78	24
2025-Q1	Unchanged	250	0.0%	$9,103	0.0%	$36.41	0
2024-Q4	Decreased	250	-50.0%	$5,500	0.0%	$22.00	0
2024-Q3	New	500	—	$3,370	0.0%	$6.77	21